Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASXC NASDAQ:NPCE NASDAQ:RXST NASDAQ:SNWV On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASXCAsensus Surgical$0.35$0.35$0.17▼$0.40$94.74M1.372.03 million shsN/ANPCENeuroPace$9.83-1.4%$9.22$5.45▼$18.98$325.11M1.9267,749 shs8,149 shsRXSTRxSight$9.96+1.9%$8.63$6.32▼$57.53$405.11M1.181.05 million shs73,622 shsSNWVSanuwave Health$36.47+1.1%$37.61$5.63▼$46.58$312.55M1.3950,967 shs574 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASXCAsensus Surgical0.00%0.00%0.00%0.00%+4.32%NPCENeuroPace+2.68%+9.08%+11.02%-15.72%+41.62%RXSTRxSight+9.40%+12.41%+36.02%-34.41%-81.74%SNWVSanuwave Health+0.47%-9.21%-9.23%+15.05%+3,608,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASXCAsensus Surgical$0.35$0.35$0.17▼$0.40$94.74M1.372.03 million shsN/ANPCENeuroPace$9.83-1.4%$9.22$5.45▼$18.98$325.11M1.9267,749 shs8,149 shsRXSTRxSight$9.96+1.9%$8.63$6.32▼$57.53$405.11M1.181.05 million shs73,622 shsSNWVSanuwave Health$36.47+1.1%$37.61$5.63▼$46.58$312.55M1.3950,967 shs574 shsThe Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASXCAsensus Surgical0.00%0.00%0.00%0.00%+4.32%NPCENeuroPace+2.68%+9.08%+11.02%-15.72%+41.62%RXSTRxSight+9.40%+12.41%+36.02%-34.41%-81.74%SNWVSanuwave Health+0.47%-9.21%-9.23%+15.05%+3,608,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASXCAsensus Surgical 0.00N/AN/AN/ANPCENeuroPace 2.83Moderate Buy$16.6068.92% UpsideRXSTRxSight 1.92Reduce$10.000.39% UpsideSNWVSanuwave Health 3.33Buy$55.0050.81% UpsideCurrent Analyst Ratings BreakdownLatest ASXC, RXST, SNWV, and NPCE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/8/2025RXSTRxSightZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold9/3/2025SNWVSanuwave HealthNorthland CapmkSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy9/3/2025SNWVSanuwave HealthNorthland SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageOutperform$55.008/22/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$54.00 ➝ $55.008/13/2025NPCENeuroPaceZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/13/2025NPCENeuroPaceWells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$17.00 ➝ $15.008/8/2025RXSTRxSightUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$16.00 ➝ $8.008/8/2025RXSTRxSightStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$9.00 ➝ $8.008/8/2025RXSTRxSightNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$22.00 ➝ $11.007/29/2025SNWVSanuwave HealthRoth CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$49.007/15/2025RXSTRxSightMorgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeOverweight ➝ Equal Weight$20.00 ➝ $9.00(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASXCAsensus Surgical$8.58M11.04N/AN/A$0.13 per share2.68NPCENeuroPace$79.91M4.07N/AN/A$0.27 per share36.40RXSTRxSight$139.93M2.91N/AN/A$6.98 per share1.43SNWVSanuwave Health$32.63M9.58N/AN/A($1.49) per share-24.48Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASXCAsensus Surgical-$78.43M-$0.31N/AN/AN/A-902.25%-184.10%-114.75%N/ANPCENeuroPace-$27.14M-$0.84N/AN/AN/A-29.29%-168.61%-25.48%11/11/2025 (Estimated)RXSTRxSight-$27.45M-$0.80N/AN/AN/A-21.93%-11.56%-10.31%11/6/2025 (Estimated)SNWVSanuwave Health-$31.37M-$8.25N/A∞N/A-97.03%N/A-135.15%N/ALatest ASXC, RXST, SNWV, and NPCE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025NPCENeuroPace-$0.24-$0.26-$0.02-$0.26$23.08 million$23.52 million8/8/2025Q2 2025SNWVSanuwave Health-$0.09$0.01+$0.10$0.01$10.14 million$10.16 million8/7/2025Guidance UpdateRXSTRxSight-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASXCAsensus SurgicalN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASXCAsensus SurgicalN/A1.000.69NPCENeuroPace3.025.474.51RXSTRxSightN/A13.9312.70SNWVSanuwave HealthN/A0.430.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASXCAsensus Surgical9.35%NPCENeuroPace78.83%RXSTRxSight78.78%SNWVSanuwave Health42.53%Insider OwnershipCompanyInsider OwnershipASXCAsensus Surgical2.87%NPCENeuroPace20.50%RXSTRxSight9.57%SNWVSanuwave Health14.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASXCAsensus Surgical170272.33 million264.52 millionNot OptionableNPCENeuroPace17033.08 million26.30 millionOptionableRXSTRxSight22040.92 million37.00 millionOptionableSNWVSanuwave Health408.57 million7.29 millionN/AASXC, RXST, SNWV, and NPCE HeadlinesRecent News About These CompaniesSanuwave Health (NASDAQ:SNWV) Downgraded to Buy Rating by Wall Street ZenSeptember 9 at 3:29 AM | marketbeat.comSanuwave Health (NASDAQ:SNWV) Stock Rating Lowered by Wall Street ZenSeptember 9 at 3:29 AM | marketbeat.comSanuwave Health (NASDAQ:SNWV) Downgraded to "Buy" Rating by Wall Street ZenSeptember 8 at 2:49 AM | americanbankingnews.comNorthland Capmk Forecasts Sanuwave Health Q3 EarningsSeptember 7 at 6:50 AM | marketbeat.comSanuwave Health (NASDAQ:SNWV) Upgraded to "Strong-Buy" at Northland CapmkSeptember 6, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Upgraded by Northland Capmk to Strong-Buy RatingSeptember 6, 2025 | americanbankingnews.comSanuwave Health (NASDAQ:SNWV) Earns Outperform Rating from Analysts at Northland SecuritiesSeptember 6, 2025 | americanbankingnews.comNorthland Capmk Predicts Sanuwave Health Q3 EarningsSeptember 6, 2025 | americanbankingnews.comSanuwave Health (NASDAQ:SNWV) Now Covered by Northland SecuritiesSeptember 5, 2025 | marketbeat.comAWM Investment Company Inc. Invests $18.15 Million in Sanuwave Health Inc. $SNWVSeptember 5, 2025 | marketbeat.comSolas Capital Management LLC Invests $20.66 Million in Sanuwave Health Inc. $SNWVSeptember 2, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Rating Increased to Strong-Buy at Wall Street ZenSeptember 1, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Upgraded to Strong-Buy at Wall Street ZenAugust 31, 2025 | americanbankingnews.comSanuwave Health (NASDAQ:SNWV) Releases Earnings Results, Beats Estimates By $0.10 EPSAugust 10, 2025 | marketbeat.comSanuwave Health (NASDAQ:SNWV) Rating Increased to Buy at Wall Street ZenAugust 10, 2025 | marketbeat.comSANUWAVE Health, Inc. (SNWV) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comSanuwave (SNWV) Q2 Revenue Jumps 42%August 8, 2025 | fool.comSanuwave Announces Q2 FY2025 Financial ResultsAugust 8, 2025 | globenewswire.comSanuwave Will Host a Conference Call on August 8, 2025 at 8:30 AM (ET) to Present Q2 2025 Financial ResultsAugust 4, 2025 | globenewswire.comSanuwave Health to Present at Canaccord Genuity Growth ConferenceJuly 22, 2025 | globenewswire.comSanuwave: High Growth Wound Care Tech Primed For A BreakoutJune 11, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeASXC, RXST, SNWV, and NPCE Company DescriptionsAsensus Surgical NYSEAMERICAN:ASXC$0.35 0.00 (0.00%) As of 08/22/2024Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.NeuroPace NASDAQ:NPCE$9.83 -0.14 (-1.43%) As of 10:18 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.RxSight NASDAQ:RXST$9.96 +0.18 (+1.85%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.Sanuwave Health NASDAQ:SNWV$36.47 +0.38 (+1.05%) As of 09:57 AM EasternSANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Oracle Has Spoken: AI Changes Everything Is Qualcomm Tesla’s Next Rival in Autonomous Driving? Casey’s General Stores: Investors Win With CASY at the Bat Should You Buy Figma Stock After Its 55% Post-IPO Drop? Ulta Beauty Stock: Strong Growth, Short-Term Volatility Ahead Joby's Stock Is Quiet, But a Storm of Catalysts Is Brewing Beyond DIY: Home Depot's Conquest of the Professional Market The Quiet Before the Catalyst: Vertical Aerospace's Next Move Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
